dr. eradat discusses data with acalabrutinib in cll
Published 4 years ago • 148 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:28
dr. eradat discusses unmet needs in cll
-
2:00
dr. barrientos discusses acalabrutinib in cll
-
1:41
dr. logan discusses acalabrutinib in cll
-
1:58
dr. eradat on the captivate trial in cll
-
1:25
dr. abedin discusses differences between acalabrutinib and ibrutinib in cll
-
1:20
dr. kay discusses the role of acalabrutinib in cll
-
1:47
dr. barrientos on the role of acalabrutinib in cll
-
7:19
acalabrutinib’s role in treating chronic lymphocytic leukemia
-
1:21
dr. brown discusses acalabrutinib in cll
-
0:57
dr. byrd on alacabrutinib's mechanism of action in cll
-
1:03
dr. eradat on rituximab biosimilar in cd20 b-cell nhl and cll
-
0:43
using acalabrutinib in cll patients with ibrutinib intolerance
-
0:50
dr. furman on acalabrutinib monotherapy in cll
-
0:51
dr. seymour on the pfs benefit with acalabrutinib with or without obinutuzumab in cll
-
1:20
dr. woyach on 3-year follow-up of acalabrutinib/obinutuzumab combo in cll
-
1:39
dr. woyach on the role of acalabrutinib in cll
-
1:03
dr. woyach on the safety of acalabrutinib versus ibrutinib in cll
-
1:33
dr. jacobs on the efficacy of ibrutinib and acalabrutinib in patients with mcl
-
1:22
dr. awan on utilizing acalabrutinib in cll